SCHEMBL3296201

SCHEMBL3296201

CCCCOc1ccc(OCCCC)c([SiH](O[SiH](c2c(OCCCC)ccc(OCCCC)c2OCCCC)c2c(OCCCC)ccc(OCCCC)c2OCCCC)c2c(OCCCC)ccc(OCCCC)c2OCCCC)c1OCCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TLR8 Q9NR97 1/20 0.36
GLA P06280 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TLR4 O00206 1/20 0.36
CHRM2 P08172 2/20 0.35
TSHR P16473 2/20 0.35
CHRM1 P11229 1/20 0.35
ALOX15 P16050 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3297756 0.81 CYP1A2 (0.52) LMNAMAPTCYP1A2CYP2C9CYP2C19
SCHEMBL3298713 0.81 LMNA (0.40) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1984241 0.80 CYP1A2 (0.52) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL3298406 0.79 KDM4E (0.39) KDM4EALDH1A1MAPTTLR8SMN1; SMN2
SCHEMBL3296216 0.76 CYP1A2 (0.46) KDM4EMAPTCYP1A2CYP2C9CYP2C19
SCHEMBL3294491 0.76 CYP1A2 (0.46) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL3296107 0.75 L3MBTL1 (0.45) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL3296223 0.73 LTA4H (0.39) CYP1A2CYP2C9CYP2C19TLR8TSHR
SCHEMBL1238407 0.72 LMNA (0.60) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL3297597 0.72 CYP1A2 (0.42) LMNAKDM4EALDH1A1NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 LMNA 791/4885KDM4E 1578/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.